Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK By Reuters
Investing.com· 17 hours agoPfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) asked a London court to revoke rival Moderna...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 15 hours agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 10 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Where Will Pfizer Stock Be in 10 Years?
Motley Fool via Yahoo Finance· 2 weeks agoPfizer (NYSE: PFE) stock has been struggling for a while now. In the past 12 months, it has declined by 36%. A lack of growth recently, a dependence on...
Is Pfizer Stock the Biggest Bargain in the S&P 500?
Motley Fool via Yahoo Finance· 2 weeks agoPfizer (NYSE: PFE) stock is relatively cheap. I can easily back up that claim. The big drugmaker's shares trade at lower forward earnings multiples than...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 20 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 14 hours agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
InvestorPlace· 10 hours agoThis seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma...
Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?
Zacks via Yahoo Finance· 2 weeks agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...